Trans-channel fluorescence learning improves high-content screening for Alzheimer's disease therapeutics
D. R. Wong, J. Conrad, N. Johnson, J. I. Ayers, A. Laeremans, J. C. Lee, J. Lee, S. B. Prusiner, S. Bandyopadhyay, A. J. Butte, N. A. Paras, M. J. Keiser
This paper introduces a deep learning method to improve high-content screening for Alzheimer's disease therapeutics by generating predicted fluorescent signals from alternative markers.
bioRxiv · Jan 8, 2021Pharmacology & Toxicology